Old Web
English
Sign In
Acemap
>
authorDetail
>
Thomas Prebet
Thomas Prebet
University of Texas MD Anderson Cancer Center
Medicine
Cytarabine
Immunology
Chemotherapy
in patient
5
Papers
25
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase i and pharmacokinetic study of elacytarabine, a novel 5′-elaidic acid derivative of cytarabine, in adults with refractory hematological malignancies
2012
Leukemia
Francis J. Giles
Norbert Vey
David A. Rizzieri
Farhad Ravandi
Thomas Prebet
G. Borthakur
Tove Flem Jacobsen
Steinar Hagen
B Nilsson
Stephen J. O’Brien
Show All
Source
Cite
Save
Citations (18)
leukemia alternative pathway of MYC activation in T-cell acute lymphoblastic Posttranscriptional deregulation of MYC via PTEN constitutes a major
2011
Vahid Asnafi
Dominique Payet-Bornet
Bertrand Nadel
W. Langerak
Thomas Prebet
Norbert Vey
Gérard Michel
Jean Soulier
Sandrine Roulland
Christine Formisano-Tréziny
Willem A. Dik
Claude Bagnis
C. Fossat
Lucie Hernandez
Mélanie Bonnet
Marie Loosveld
Bertrand Montpellier
Jean-Marc Navarro
Benoit Quilichini
Show All
Source
Cite
Save
Citations (0)
A phase I study with CP-4055 in patients with hematologic malignancies
2008
Journal of Clinical Oncology
S. M. OBrien
Norbert Vey
David A. Rizzieri
H. Kantarjian
Thomas Prebet
Farhad Ravandi
Tove Flem Jacobsen
B Nilsson
Karin Staudacher
Francis J. Giles
Show All
Source
Cite
Save
Citations (3)
A Phase I/II Study with CP-4055 in Patients with Haematologic Malignancies.
2007
Blood
Francis J. Giles
Hagop M. Kantarjian
Norbert Vey
David A. Rizzieri
Farhad Ravandi
Thomas Prebet
Tove Flem Jacobsen
B Nilsson
Karin Staudacher
Susan OBrien
Show All
Source
Cite
Save
Citations (4)
1